The pan-CLK/DYRK inhibitor cirtuvivint selectively disrupts alternative splicing and has broad anti-tumor activity in preclinical modelsElizabeth A. McMillan,Carine Bossard,Emily Creger,Carsten Merkwirth,Raffaella Pippa,Matthew Jarvis,Krishna Sriram,Melinda Pedraza,Maureen Ibanez,Deepti Bhat,Carolyn Lai,Josh Stewart,Brian Eastman,Chi-Ching Mak,Michael A. White, Darrin BeaupreCANCER RESEARCH(2022)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要